Design and implementation of single switch integrated boost and flyback converter for renewable and sustainable energy.

Renewable resources are being explored to meet the increasing energy demand in the world. The development of RES and their integration into the grid necessitate a voltage conversion to match with the grid voltage. This conversion can be implemented using DC-DC converters. A high-gain DC-DC Converter with low loss is proposed in this article. Thus, the proposed integrated converter is obtained by incorporating a boost converter at the primary side of the flyback converter (FLC) and a VM cell at the secondary side to perform a elevated voltage gain at a lower duty ratio. The Switched Capacitor network is implemented to elevate the voltage gain. The dynamic performance of a controller can be enhanced using an FOPID controller. A comparison analysis has been done using the most recent topologies in order to confirm the superiority of the Proposed converter. A 100W experimental prototype model has been constructed in order to further validate the simulation results. The efficiency of this converter is demonstrably significantly higher than the current topology, according to measured performance. Therefore, it can be said that this topology can be used for applications involving renewable and sustainable energy.

A Comparative Study of Serum Uric Acid levels and Lipid Ratios in Coronary Artery Disease Patients.

INTRODUCTION: Coronary Artery Disease (CAD) appears to be common in the Indian population of different geographical origins, religions and languages. Measurement of lipid fractions and ratios are widely recommended for risk assessment. A few studies have shown that serum uric acid plays a role in the development of cardiovascular morbidity. Very few reports are cited linking serum uric acid with the lipid fraction in CAD. OBJECTIVES: To find the significance of non-HDL cholesterol, LDL-c/HDL-c ratio, TC/HDL ratio and serum uric acid level in CAD patients. SUBJECTS AND METHODOLOGY: In this study, we included fifty CAD patients as subjects and an equal number of controls. Both subjects and controls were assessed for anthropometric, physiological and biochemical parameters. RESULTS: The present study showed significant increased levels of total cholesterol (p=0.002), TAGs (p<0.001), HDL (p=0.005), LDL (p<0.006) and non-HDL cholesterol (p<0.001). LDL-c/HDL-c ratio (p<0.001) and TC/HDL ratio (p<0.001) in CAD patients (subjects) were also significant when compared to controls. Uric acid level in CAD patients was increased (p<0.001). CONCLUSION: Serum Uric Acid, TC/HDL and LDL/HDL ratios could be regarded as objective markers, in association with existing atherogenic dyslipidemia in patients with CAD.